Through research on stomach cancer, it was discovered that baicalin inhibits the expression of three important glycolysis enzymes, HK2, LDHA, and PDK, reducing the rate of glycolysis and reversing the hypoxia-induced sensitivity of AGS cells to pentafluorouracil (Chen et al., 2015). The gene discussed is HK2; the disease is gastric cancer.